Today’s guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred returns to the program to explore the next frontier of AI-driven drug discovery. Building on the previous discussion, this episode delves into the transformative role of automation, data generation, and predictive modeling in pharmaceutical development. This episode is sponsored by Iambic Therapeutics. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.